# Differentiating the Effects of Substance P and Beta-endorphin

> **NCT01854177** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01854177
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854177, "Differentiating the Effects of Substance P and Beta-endorphin". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01854177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*